Renal Transplanted RecipientsNCT06707792
Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients
An observational study of Renal Transplanted Recipients, run by Hacettepe University at 1 site in Turkey (Türkiye).
Trial summary
The aim of our study was to investigate the validity and reliability of the 6 minute stepper test in kidney transplant recipients. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Renal Transplanted Recipients
- How many people
- 45 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 9 Jun 2024to 14 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Kidney transplant recipients will be included.
Who may be able to join
- Patients with kidney transplantation
- At least 6 months after the kidney transplant
- Voluntary participation in the study
Who cannot join
- Having a musculoskeletal problem that may interfere with the tests
- Having neurological impairment
- Having chronic lung disease
- Having had any cardiovascular event in the last 6 months
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Investigation of Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients
The aim of our study was to investigate the validity and reliability of the 6 minute stepper test in kidney transplant recipients.
- Conditions
- Renal Transplanted Recipients
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Kidney transplant recipients | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise capacity
Exercise capacity will be assessed with a 6 minute stepper test.
Measured: Day 1
Exercise capacity
Exercise capacity will be assessed with a 6 minute walk test.
Measured: Day 1
Peripheral muscle strength
Knee extensor strength will be measured using a portable portable handheld dynamometer.
Measured: Day 1
Lower extremity endurance
It will be evaluated with a one-minute sit to stand test.
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Nov 2024
- Study start9 Jun 2024
- Primary completion8 Nov 2025
- Study completion14 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Renal Transplanted RecipientsStudies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Firat, Kirsehir Ahi Evran Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06707792
- Sponsor's protocol ID
- GO 23/604
- Status last verified
- Nov 2024
- First submitted
- 25 Nov 2024
- Last updated
- 20 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients
- ClinicalTrials.gov ID
- NCT06707792
- Acronym / sponsor ID
- GO 23/604
- Conditions
- Renal Transplanted Recipients
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 9 Jun 2024 (actual)
- Primary completion
- 8 Nov 2025 (actual)
- Study completion
- 14 Dec 2025 (actual)
- First posted
- 27 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of our study was to investigate the validity and reliability of the 6 minute stepper test in kidney transplant recipients.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Kidney transplant recipients | – | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Kidney transplant recipients will be included.
Key inclusion criteria (3 listed)
- Patients with kidney transplantation
- At least 6 months after the kidney transplant
- Voluntary participation in the study
Key exclusion criteria (4 listed)
- Having a musculoskeletal problem that may interfere with the tests
- Having neurological impairment
- Having chronic lung disease
- Having had any cardiovascular event in the last 6 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Exercise capacity
Time frame: Day 1
Exercise capacity will be assessed with a 6 minute stepper test.
Exercise capacity
Time frame: Day 1
Exercise capacity will be assessed with a 6 minute walk test.
Peripheral muscle strength
Time frame: Day 1
Knee extensor strength will be measured using a portable portable handheld dynamometer.
Lower extremity endurance
Time frame: Day 1
It will be evaluated with a one-minute sit to stand test.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2026.
Related trials for Renal Transplanted Recipients
RecruitingPhase 2
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
Antibody-Mediated Rejection (AMR)
Not yet recruitingEarly Phase 1
Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients
Kidney Transplant Recipient
Recruiting
Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study
Pediatric Kidney Disease, Transplant;Failure,Kidney
Not yet recruitingPhase 2
(TNX-1500) in Kidney Transplant Recipients
Kidney Transplant, Kidney Transplant Failure and Rejection
Active, not recruitingPhase 1/2
Carfilzomib and Belatacept for Desensitization
Highly Sensitized Prospective Kidney Transplant Recipients
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Renal Transplanted Recipients, run by Hacettepe University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise capacity (time frame: Day 1). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.